T. Rowe Price Investment Management, Inc. Crispr Therapeutics Ag Transaction History

T. Rowe Price Investment Management, Inc.

$164 Billion
Q3 2025

A detailed history of T. Rowe Price Investment Management, Inc. transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 3,282,584 shares of CRSP stock, worth $182 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

3,282,584

Previous 3,683,026 10.87%

Holding current value

$182 Million

Previous $179 Million 18.76%

% of portfolio

0.13%

Previous 0.11%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$48.51 - $68.14 $19.4 Million - $27.3 Million	-400,442 Reduced 10.87%	3,282,584 $213 Million
Q2 2025 Aug 14, 2025	SELL	$31.27 - $48.64 $3.6 Million - $5.6 Million	-115,077 Reduced 3.03%	3,683,026 $179 Million
Q1 2025 May 14, 2025	SELL	$34.03 - $53.02 $462,978 - $721,337	-13,605 Reduced 0.36%	3,798,103 $129 Million
Q4 2024 Feb 14, 2025	BUY	$38.65 - $55.15 $41.5 Million - $59.2 Million	1,074,238 Added 39.24%	3,811,708 $150 Million
Q3 2024 Nov 14, 2024	BUY	$44.62 - $62.75 $304,219 - $427,829	6,818 Added 0.25%	2,737,470 $129 Million
Q2 2024 Aug 14, 2024	BUY	$51.17 - $68.18 $1.35 Million - $1.79 Million	26,321 Added 0.97%	2,730,652 $147 Million
Q1 2024 May 15, 2024	SELL	$60.67 - $89.12 $55 Million - $80.8 Million	-906,855 Reduced 25.11%	2,704,331 $184 Million
Q4 2023 Feb 14, 2024	SELL	$38.62 - $72.18 $1.57 Million - $2.93 Million	-40,647 Reduced 1.11%	3,611,186 $226 Million
Q3 2023 Nov 14, 2023	BUY	$45.39 - $59.0 $238,342 - $309,809	5,251 Added 0.14%	3,651,833 $166 Million
Q2 2023 Aug 14, 2023	SELL	$43.47 - $67.77 $773,287 - $1.21 Million	-17,789 Reduced 0.49%	3,646,582 $205 Million
Q1 2023 May 15, 2023	BUY	$41.0 - $56.12 $27.5 Million - $37.6 Million	670,794 Added 22.41%	3,664,371 $166 Million
Q4 2022 Feb 14, 2023	BUY	$39.19 - $65.67 $29.5 Million - $49.4 Million	752,132 Added 33.56%	2,993,577 $122 Million
Q3 2022 Nov 14, 2022	BUY	$61.1 - $83.78 $137 Million - $188 Million	2,241,445 New	2,241,445 $146 Million

Others Institutions Holding CRSP

# of Institutions

549

Shares Held

67.7M

Call Options Held

3.56M

Put Options Held

3.11M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $4.32B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of T. Rowe Price Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on T. Rowe Price Investment Management, Inc. with notifications on news.

Account

T. Rowe Price Investment Management, Inc. Crispr Therapeutics Ag Transaction History